Premaitha Health (NIPT)

 

NIPT Share PerformanceMore

52 week high14.4000 06/03/17
52 week low4.9611 15/12/17
52 week change -3.5000 (-40.00%)
4 week volume28,648,003 20/11/17

Media for (NIPT)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Premaitha Health adds laboratories in Europe

Premaitha Health said it has expanded its European customer base with the addition of four new laboratories. They would...

Premaitha secures four further laboratories in EU

RNS Number: 8857Y Premaitha Health PLC 11 December 2017 Premaitha Health PLC (" Premaitha " or the "Company " ) Premaitha secures four further laboratories in Europe Manchester, UK - 11 December 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), announces fu...

Premaitha CEO Wins Outstanding Contribution Award

RNS Number: 1260Y Premaitha Health PLC 01 December 2017 Premaitha CEO Wins Bionow Outstanding Contribution Award Manchester, UK - 1 December 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), is proud to announce that its CEO, Dr Stephen Little, last night r...

Premaitha Health opening four new Middle East labs

Premaitha Health said it will open four new laboratories in the Middle East for customers seeking to offer its test for Dow...

Middle East laboratory network expansion

RNS Number: 5292X Premaitha Health PLC 27 November 2017 Premaitha Health PLC (" Premaitha " or the "Company " ) Middle East laboratory network expansion Manchester, UK - 27 November 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), announces further ex...

Premaitha signs NIPT partner in East Asia

Premaitha Health, a molecular diagnostics group focused on non-invasive prenatal testing (NIPT), has signed an agreement...

Premaitha signs new partner in East Asia

RNS Number: 2928X Premaitha Health PLC 23 November 2017 Premaitha Health plc ("Premaitha" or the "Company") Premaitha signs new partner to offer NIPT solution in East Asia Manchester, UK - 23 November 2017: Premaitha Health plc (AIM: NIPT), a leading international molecular diagnostics group focused on non-invasive prenatal testing ("NIPT"), annou...

Premaitha updates on patent disputes

Premaitha Health has confirmed that the High Court has today delivered its first instance judgment in respect of the ongo...

Fundamental DataMore

EPS-3
Dividend yield0 %

Latest discussion posts More

  • Re: Yikes! Judge rules for Illumina

    That will depend on whether they have patents in those other countries. I'm sure they don't have a global patent. Essentially they will need to get around the negotiations ...
    23-Nov-2017
    Mr Papillon
  • Re: Yikes! Judge rules for Illumina

    Do you not think this will now be pursued by Illumina in all other jurisdictions?
    22-Nov-2017
    RichardLY
  • Re: Yikes! Judge rules for Illumina

    UK only it seems but a sad situation for women in the UK as the test will likely be withdrawn and they will have to hop on a plane to take it somewhere else. Obviously the ...
    22-Nov-2017
    Peermade

Users' HoldingsMore

Users who hold Premaitha Health also hold..

Codes & Symbols

ISINGB00BN31ZD89
SymbolsNIPT, LSE:NIPT, NIPT.L, NIPT:LN, LON:NIPT, XLON:NIPT

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account